同济大学学报（医学版）2017，Vol.38Issue(2)：120-124,5.DOI:10.16118/j.1008-0392.2017.02.025
雄激素受体在乳腺癌中的研究进展
Progression on androgen receptor in breast cancer
摘要
Abstract
About 70％ of human breast cancers express androgen receptor(AR).Studies suggest that AR may play a role in pathogenesis of breast cancer and serve as a therapeutic target in certain types of breast cancer,such as triple-negative breast cancer(TNBC).Although this is an active research area,the clinical significance of AR as a prognostic marker and its role in tumorigenesis is unclear yet.At present,the research of AR in breast cancer becomes a new hotspot.This article reviews the research progress of the relationship between AR and breast cancer.关键词
雄激素受体/乳腺癌/三阴性乳腺癌Key words
androgen receptor/breast cancer/triple-negative breast cancer分类
医药卫生引用本文复制引用
钟镇铧..雄激素受体在乳腺癌中的研究进展[J].同济大学学报（医学版）,2017,38(2):120-124,5.基金项目
国家自然科学基金(81272240) （81272240）
